Track topics on Twitter Track topics that are important to you
The FDA will give special treatment to Vaximm’s oral T cell immunotherapy for glioma, which is particularly difficult to treat. Vaximm focuses on the development of oral T cell immunotherapies for cancers. The FDA and European Commission have given Vaximm’s glioma candidate, VXM01, orphan designation, ...
This awesome article Swiss Biotech’s Immunotherapy for Brain Cancer gets Orphan Drug Designation appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)NEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...